Cancer drug development: The missing links
AB Kunnumakkara, D Bordoloi… - Experimental …, 2019 - journals.sagepub.com
Although better science and technology has been linked with better health care, however,
reality is much different. Although America and most of Europe are equipped with most …
reality is much different. Although America and most of Europe are equipped with most …
[HTML][HTML] Pharmacoeconomic evaluations of CDK4/6 inhibitors plus endocrine therapy for advanced hormone receptor-positive (HR+) and human epidermal growth …
L Zhu, M Wang, X Luo, H Li, H Shan… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Hormone receptor-positive (HR+) and human epidermal growth factor receptor-
2 negative (HER2−) breast cancer is the most common molecular subtype of breast cancer …
2 negative (HER2−) breast cancer is the most common molecular subtype of breast cancer …